ICON Public Limited Company

ICON Public Limited Company

ICLR · Nasdaq

ICON Public Limited Company (ICLR) is a Medical diagnostics research company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for ICON Public Limited Company in 2026. The next earnings report is expected on October 28, 2026.

Earnings calendar

Next earnings date

28 Oct 2026

In 69 days

EPS estimate

2.71

Revenue estimate

2.0B

Past earnings

29 Jul 2026
EPS actual
2.56 (+0.6%)
estimate 2.55
Revenue actual
2.1B (+3.0%)
estimate 2.0B
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
23 Jun 2026
EPS actual
2.50 (+2.8%)
estimate 2.43
Revenue actual
2.0B (+1.8%)
estimate 2.0B
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
13 May 2026
EPS actual
estimate 2.79
Revenue actual
estimate 1.9B
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
30 Apr 2026
EPS actual
3.23 (+1.3%)
estimate 3.19
Revenue actual
2.0B (+0.5%)
estimate 2.0B
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
22 Oct 2025
EPS actual
3.31 (+0.3%)
estimate 3.30
Revenue actual
2.0B (+3.0%)
estimate 2.0B
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Beat Miss usd

Latest earnings analysis

ICON Public Limited Company beat consensus estimates in its latest earnings, with EPS of USD 2.56 coming in 0.6% above expectations and revenue of USD 2.06 billion exceeding estimates by 3.0%. Both EPS and revenue were also ahead of expectations in the previous report.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Sector
Healthcare
Industry
Medical diagnostics research
Country
Ireland
Exchange
Nasdaq
CEO
Barry Balfe
Employees
41,250
IPO date
15 May 1998
ISIN
IE0005711209
Website
iconplc.com

Frequently asked questions

When does ICON Public Limited Company (ICLR) next report earnings?

ICON Public Limited Company (ICLR) is scheduled to report earnings on October 28, 2026.

What was ICON Public Limited Company's most recent earnings date?

ICON Public Limited Company (ICLR) last reported earnings on July 29, 2026.

Where is ICON Public Limited Company stock listed?

ICON Public Limited Company (ICLR) is listed on Nasdaq.